News | March 02, 2012

FDA Panel Meeting Scheduled for U-Systems’ Automated Breast Ultrasound (ABUS) System

The somo•v Automated Breast Ultrasound is the First Ultrasound Device to Target Breast Cancer Screening Indication

March 2, 2012 — U-Systems announced the somo•v automated breast ultrasound (ABUS) system is scheduled for review by the Radiological Devices Panel of the U.S. Food and Drug Administration (FDA) on April 11, 2012. The FDA Advisory Panel review is the next step in the firm’s premarket approval (PMA) application seeking a breast cancer screening indication for the system. The somo•v ABUS system is currently FDA-cleared for diagnostic use as an adjunct to mammography.

“We are very excited the somo•v ABUS system has been scheduled for review at the upcoming Radiological Devices Advisory Panel meeting,” said Ron Ho, president and CEO of U-Systems. “This is a significant milestone, not only for the company, but also for women with dense breast tissue. The limitation of mammography in women with dense breasts is well documented. This panel review, part of the FDA process for assessing new technology, brings us one step closer to an approved adjunctive screening tool for women with dense breasts. This is vitally important, because an estimated 40-45 percent of women in the United Stated have dense breast tissue.”

Dense breast tissue not only increases the risk of breast cancer up to four to six times but also makes cancer more difficult to detect via mammography according to multiple large studies. A study published in the New England Journal of Medicine showed 35 percent of breast cancer goes undetected by mammography in women with dense breasts, as the density masks appearance of tumors. The greater the breast density, the lower the mammogram accuracy.

Over the past several years, U-Systems has worked with some of the nation’s leading breast imaging experts to conduct a large, multi-center prospective clinical study to evaluate the ability of somo•v automated breast ultrasound screening to improve cancer detection rates for women with dense breast tissue. The SOMO•INSIGHT clinical study, the largest trial ever undertaken by an ultrasound company, is designed to evaluate whether digital mammography in combination with the automated breast ultrasound system is more sensitive than a routine screening mammogram alone in detecting breast cancer in women with dense breast tissue. More than 16,000 women have enrolled in the study at multiple breast imaging centers nationwide.

For more information: www.u-systems.com

Related Content

Fujifilm Installing New DR Equipment for Three Large Healthcare Systems
News | Digital Radiography (DR) | September 22, 2017
Fujifilm Medical Systems U.S.A. Inc. recently closed new contracts to enhance diagnostic imaging capabilities for...
Philips Introduces New OB/GYN Ultrasound Innovations at ISUOG 2017. Vivian Fornell
News | Ultrasound Womens Healthcare | September 19, 2017
September 19, 2017 — Philips announced new OB/GYN innovations at the 27th World Congress on Ultrasound in Obstetrics
DenseBreast-info.org Debuts  Spanish Language Video  About Dense Breasts
News | Breast Density | September 12, 2017
Breast cancer risks associated with breast density are the subject of a new Spanish language video launched recently by...
Asian Study Underlines Potential Value of Pressure-Guided Mammography
News | Mammography | September 11, 2017
Sigmascreening recently announced that a study of in total 15,898 in digital mammograms from 3,772 Asian women...
Delphinus Enrolls First Patient in Discover Breast Ultrasound Clinical Project
News | Ultrasound Womens Healthcare | September 08, 2017
September 8, 2017 — Delphinus Medical Technologies Inc.
FDA Clears Senographe Pristina Mammography System With Patient-Assisted Compression
Technology | Mammography | September 05, 2017
The U.S. Food and Drug Administration (FDA) cleared GE Healthcare’s Senographe Pristina with Self-Compression, the...
FDA Releases Six-Month Inspection Data From EQUIP Mammography Quality Initiative
News | Mammography | September 01, 2017
September 1, 2017 — The Division of Mammography Quality Standards (DMQS) of the U.S.
Comparison of Screening Recommendations Supports Annual Mammography. Marilyn Fornell
News | Mammography | August 22, 2017
When to initiate screening for breast cancer, how often to screen, and how long to screen are questions that continue...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Volpara Solutions to Showcase Volpara Enterprise DDP Software at AHRA 2017
News | Mammography | July 11, 2017
Volpara Solutions Inc. will showcase its new Volpara Enterprise DDP software at the Association for Medical Imaging...
Overlay Init